An open-label, long-term safety and tolerability study of b1ivaracetam as adjunctive treatment in pediatric study participants with epilepsy
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
UCB Biopharma
Start Date
May 12, 2021
End Date
January 31, 2023
Administered By
Pediatrics, Neurology
Awarded By
UCB Biopharma
Start Date
May 12, 2021
End Date
January 31, 2023